Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support
Open Access
- 14 December 2010
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 86 (3) , 245-250
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye?Blood, 2009
- Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blastsLeukemia Research, 2009
- Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyHaematologica, 2009
- Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirementsAnnals of Hematology, 2009
- How I treat patients with myelodysplastic syndromesBlood, 2009
- The deleterious effects of iron overload in patients with myelodysplastic syndromesBlood Reviews, 2008
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007
- Retrospective nationwide survey of Japanese patients with transfusion‐dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortalityEuropean Journal of Haematology, 2007
- Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationBlood, 2007
- Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision MakingJournal of Clinical Oncology, 2005